Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 28

1.

Continuation and adherence rates on initially-prescribed intensive secondary prevention therapy after Rapid Access Stroke Prevention (RASP) service assessment.

Murphy SJ, Coughlan CA, Tobin O, Kinsella J, Lonergan R, Gutkin M, McCabe DJ.

J Neurol Sci. 2016 Feb 15;361:13-8. doi: 10.1016/j.jns.2015.12.009. Epub 2015 Dec 8.

PMID:
26810509
2.

Visualisation of the medial longitudinal fasciculus using fibre tractography in multiple sclerosis patients with internuclear ophthalmoplegia.

McNulty JP, Lonergan R, Bannigan J, O'Laoide R, Rainford LA, Tubridy N.

Ir J Med Sci. 2016 Jan 19. [Epub ahead of print]

PMID:
26787313
3.

Delayed P100-Like Latencies in Multiple Sclerosis: A Preliminary Investigation Using Visual Evoked Spread Spectrum Analysis.

Kiiski HS, Ní Riada S, Lalor EC, Gonçalves NR, Nolan H, Whelan R, Lonergan R, Kelly S, O'Brien MC, Kinsella K, Bramham J, Burke T, Ó Donnchadha S, Hutchinson M, Tubridy N, Reilly RB.

PLoS One. 2016 Jan 4;11(1):e0146084. doi: 10.1371/journal.pone.0146084. eCollection 2016.

4.

Closing the tau loop: the missing tau mutation.

McCarthy A, Lonergan R, Olszewska DA, O'Dowd S, Cummins G, Magennis B, Fallon EM, Pender N, Huey ED, Cosentino S, O'Rourke K, Kelly BD, O'Connell M, Delon I, Farrell M, Spillantini MG, Rowland LP, Fahn S, Craig P, Hutton M, Lynch T.

Brain. 2015 Oct;138(Pt 10):3100-9. doi: 10.1093/brain/awv234. Epub 2015 Aug 21.

PMID:
26297556
5.

Posterior cortical and white matter changes on MRI in anti-AMPA receptor antibody encephalitis.

Elamin M, Lonergan R, Killeen RP, O'Riordan S, Tubridy N, McGuigan C.

Neurol Neuroimmunol Neuroinflamm. 2015 May 21;2(4):e118. doi: 10.1212/NXI.0000000000000118. eCollection 2015 Aug. No abstract available.

6.

Back pain following a lumbar puncture--what's unusual about that?

Sinokrot O, Doyle A, Lonergan R, Fitzgerald S, McGuigan C.

Ir Med J. 2015 May;108(5):155. No abstract available.

PMID:
26062247
7.

Unmet needs of multiple sclerosis patients in the community.

Lonergan R, Kinsella K, Fitzpatrick P, Duggan M, Jordan S, Bradley D, Hutchinson M, Tubridy N.

Mult Scler Relat Disord. 2015 Mar;4(2):144-50. doi: 10.1016/j.msard.2015.01.003. Epub 2015 Feb 3.

PMID:
25787190
8.

Paraneoplastic dentate ganglionopathy: clinical and neuroimmunologic studies.

O'Toole O, Murphy O, O'Dwyer J, Lonergan R, Keogh B, Tubridy N, Lynch T, Farrell M.

Clin Neuropathol. 2015 Jan-Feb;34(1):34-9. doi: 10.5414/NP300754.

PMID:
25074875
9.

Diagnostic Efficacy of Conventional MRI Pulse Sequences in the Detection of Lesions Causing Internuclear Ophthalmoplegia in Multiple Sclerosis Patients.

McNulty JP, Lonergan R, Brennan PC, Evanoff MG, O'Laoide R, Ryan JT, Tubridy N.

Clin Neuroradiol. 2015 Sep;25(3):233-9. doi: 10.1007/s00062-014-0295-5. Epub 2014 Mar 6.

PMID:
24599322
10.

Frequent inaccuracies in ABCD2 scoring in non-stroke specialists' referrals to a daily Rapid Access Stroke Prevention service.

Bradley D, Cronin S, Kinsella JA, Tobin WO, Mahon C, O'Brien M, Lonergan R, Cooney MT, Kennelly S, Collins DR, O'Neill D, Coughlan T, Smyth S, McCabe DJ.

J Neurol Sci. 2013 Sep 15;332(1-2):30-4. doi: 10.1016/j.jns.2013.05.030. Epub 2013 Jul 17.

PMID:
23871489
11.

Symptom overlap in anxiety and multiple sclerosis.

Ó Donnchadha S, Burke T, Bramham J, O'Brien MC, Whelan R, Reilly R, Kiiski H, Lonergan R, Kinsella K, Kelly S, McGuigan C, Hutchinson M, Tubridy N.

Mult Scler. 2013 Sep;19(10):1349-54. doi: 10.1177/1352458513476742. Epub 2013 Feb 14.

PMID:
23413298
12.

Only low frequency event-related EEG activity is compromised in multiple sclerosis: insights from an independent component clustering analysis.

Kiiski H, Reilly RB, Lonergan R, Kelly S, O'Brien MC, Kinsella K, Bramham J, Burke T, O Donnchadha S, Nolan H, Hutchinson M, Tubridy N, Whelan R.

PLoS One. 2012;7(9):e45536. doi: 10.1371/journal.pone.0045536. Epub 2012 Sep 21.

13.

Immunomodulators for multiple sclerosis may ameliorate spinal bone loss.

McKenna MJ, Murray B, Lonergan R, Redmond JM.

Ir J Med Sci. 2013 Mar;182(1):29-32. doi: 10.1007/s11845-012-0818-5. Epub 2012 Apr 7.

PMID:
22484845
14.

Change in PASAT performance correlates with change in P3 ERP amplitude over a 12-month period in multiple sclerosis patients.

Kiiski H, Reilly RB, Lonergan R, Kelly S, O'Brien M, Kinsella K, Bramham J, Burke T, O'Donnchadha S, Nolan H, Hutchinson M, Tubridy N, Whelan R.

J Neurol Sci. 2011 Jun 15;305(1-2):45-52. doi: 10.1016/j.jns.2011.03.018. Epub 2011 Mar 31.

PMID:
21457995
15.

IL-27 mediates the response to IFN-β therapy in multiple sclerosis patients by inhibiting Th17 cells.

Sweeney CM, Lonergan R, Basdeo SA, Kinsella K, Dungan LS, Higgins SC, Kelly PJ, Costelloe L, Tubridy N, Mills KH, Fletcher JM.

Brain Behav Immun. 2011 Aug;25(6):1170-81. doi: 10.1016/j.bbi.2011.03.007. Epub 2011 Mar 21.

PMID:
21420486
16.

Multiple sclerosis prevalence in Ireland: relationship to vitamin D status and HLA genotype.

Lonergan R, Kinsella K, Fitzpatrick P, Brady J, Murray B, Dunne C, Hagan R, Duggan M, Jordan S, McKenna M, Hutchinson M, Tubridy N.

J Neurol Neurosurg Psychiatry. 2011 Mar;82(3):317-22. doi: 10.1136/jnnp.2010.220988. Epub 2011 Jan 19.

PMID:
21248317
17.

OAS1: a multiple sclerosis susceptibility gene that influences disease severity.

O'Brien M, Lonergan R, Costelloe L, O'Rourke K, Fletcher JM, Kinsella K, Sweeney C, Antonelli G, Mills KH, O'Farrelly C, Hutchinson M, Tubridy N.

Neurology. 2010 Aug 3;75(5):411-8. doi: 10.1212/WNL.0b013e3181ebdd2b.

PMID:
20679634
18.

Preliminary evidence for correlation between PASAT performance and P3a and P3b amplitudes in progressive multiple sclerosis.

Kiiski H, Whelan R, Lonergan R, Nolan H, Kinsella K, Hutchinson M, Tubridy N, Reilly RB.

Eur J Neurol. 2011 May;18(5):792-5. doi: 10.1111/j.1468-1331.2010.03172.x.

PMID:
20666835
19.

Impaired information processing speed and attention allocation in multiple sclerosis patients versus controls: a high-density EEG study.

Whelan R, Lonergan R, Kiiski H, Nolan H, Kinsella K, Hutchinson M, Tubridy N, Reilly RB.

J Neurol Sci. 2010 Jun 15;293(1-2):45-50. doi: 10.1016/j.jns.2010.03.010.

PMID:
20399448
20.

A high-density ERP study reveals latency, amplitude, and topographical differences in multiple sclerosis patients versus controls.

Whelan R, Lonergan R, Kiiski H, Nolan H, Kinsella K, Bramham J, O'Brien M, Reilly RB, Hutchinson M, Tubridy N.

Clin Neurophysiol. 2010 Sep;121(9):1420-6. doi: 10.1016/j.clinph.2010.03.019. Epub 2010 Apr 8.

PMID:
20381418
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk